<DOC>
	<DOCNO>NCT01825850</DOCNO>
	<brief_summary>The objective study investigate drug interaction Gemigliptin Irbesartan compare pharmacokinetics Gemigliptin Irbesartan administer concomitantly alone healthy male subject .</brief_summary>
	<brief_title>Pharmacokinetic Drug Interaction Study Between Gemigliptin Irbesartan After Oral Administration Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Irbesartan</mesh_term>
	<criteria>Inclusion Criteria Age 20 45 , healthy male subject ( screen ) BMI 18 27 kg/m2 ( screen ) Blood pressure SBP 90140 mmHg , DBP 6095 mmHg FPG 70125mg/dL glucose level ( screen ) Subject totally understand progress clinical trial , make decision free , signed consent form follow Exclusion Criteria Subject past present history disease follow . ( liver include hepatitis virus carrier , kidney , Neurology , immunology , pulmonary , endocrine , hematooncology , cardiology , mental disorder . ) Subject GI tract disease influencable drug absorption ( ulcer , acute chronic pancreatitis ) surgery . ( appendectomy , hernioplasty include ) Subject drug hypersensitivity reaction . ( gemigliptin , irbesartan , aspirin , antibiotic ) Subject already admit investigator product 80 day Subject whole blood donation 60 day , component blood donation 30 day transfusion 30 day currently</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>